Sveriges mest populära poddar
Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love

Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity

1 tim 1 min•29 oktober 2026

Om avsnittet

Featuring an interview with Dr Erica Mayer, including the following topics:

  • Risk Assessment and Genomic Assays for Hormone Receptor (HR)-Positive, HER2-Negative Localized Breast Cancer (0:00)
  • Investigator Survey Results on Risk Assessment and Genomic Assays (20:07)
  • Adjuvant CDK4/6 Inhibitors for High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (24:30)
  • Investigator Survey Results on Adjuvant CDK4/6 Inhibitors (30:42)
  • Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (32:07)
  • Investigator Survey Results on Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (37:44)
  • Adjuvant Oral Selective Estrogen Receptor Degraders (SERDs) for HR-Positive, HER2-Negative Localized Breast Cancer (39:05)
  • Investigator Survey Results on Adjuvant Oral SERDs (43:02)
  • Discussion of Questions from the Community (45:00)

CME information and select publications

Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.